Full name
PHARM SUPPLY SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
46.46.Z - Wholesale of pharmaceutical goods
46.45.Z - Wholesale of perfume and cosmetics
47.7 - Retail sale of other goods in specialised stores
73.11.Z - Advertising agencies activities
73.20.Z - Market research and public opinion polling
82.30.Z - Organisation of conventions and trade shows
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 1,7 | 1,1 | 2,5 | 132,9 |
EBITDA | 2,1 | 2 | 3,3 | 67,2 |
Short time liabilities | 0,7 | 2,7 | 4,1 | 49,1 |
Equity capital | 12,7 | 9,3 | 11,4 | 21,5 |
Operating profit (EBIT) | 1,8 | 1,3 | 2,4 | 85 |
Assets | 13,6 | 14 | 17,1 | 22,2 |
Net profit (loss) | 1,4 | 0,8 | 2 | 148,5 |
Cash | 5 | 1,1 | 3,7 | 234,4 |
Net income from sale | 18,7 | 21,6 | 23,8 | 9,8 |
Liabilities and provisions for liabilities | 0,8 | 4,7 | 5,8 | 23,6 |
Working assets | 13,1 | 10,7 | 14,5 | 36,4 |
Depreciation | 0,3 | 0,7 | 0,9 | 33,5 |
% | % | % | p.p. | |
Profitability of capital | 10,7 | 8,7 | 17,7 | 9 |
Equity capital to total assets | 93,9 | 66,7 | 66,3 | -0,4 |
Gross profit margin | 9,3 | 5,1 | 10,7 | 5,6 |
EBITDA Margin | 11,1 | 9,1 | 13,9 | 4,8 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 13 | 46 | 63 | 17 |
Current financial liquidity indicator | 19.619705200195312 | 4.170019149780273 | 3.717535972595215 | -0,5 |
Net dept to EBITDA | -2.217860221862793 | 0.5319346785545349 | -0.5538679361343384 | -1,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane